Joyson Electronics has farmed out a stake in its smart driving subsidiary Joy Next to investors including Baofeng Energy and Ningbo Gaofa Automotive Control System.
Month: October 2020
Nippon Life makes an impact with $100m
The insurance provider has committed $100m to the Life Science Impact Program, which is managed by Grove Street Advisors and will focus on healthcare businesses.
Sonoma secures series A extension
Lyell Immunopharma was joined by new corporate backers Lilly Asia Ventures Biosciences and Alexandria Venture Investments to bring Sonoma’s series A round to $70m.
CSS to captivate startups with $54m fund
The insurer has put $54m into a corporate venturing arm called SwissHealth Ventures to target digital health startups.
Riding the storm of change
Change is coming. The only question remains how to maximise the impact at a corporation through sophisticated use of open innovation tools, such as corporate venturing, and align them to traditional research and development and mergers and acquisitions.
Cazoo captures $308m
DMG Ventures has contributed to a $308m funding round that increased Cazoo’s overall funding to some $558m and its valuation to more than $2.5bn.
Palantir joins NYSE limelight
Sompo, Fujitsu and Relx-backed Palantir went public yesterday and fetched a $20.6bn valuation – only marginally above the $20.3bn it was worth in 2015.
BioCatch pushes series C to $168m
Barclays, Citi, HSBC and National Australia Bank have provided a $20m extension, joining a round already backed by CreditEase and American Express Ventures.
Sendinblue picks up $160m series B
Caloga-backed Sendinblue has added $160m to its coffers thanks to investors including Bpifrance and BlackRock.
SemiDrive inserts $73m series A
Nanjing SemiDrive lured the return of Lenovo Capital in a round that will help enhance its semiconductors for autonomous and connected vehicles.
Fiture whips series A into $65m shape
Tencent and Bertelsmann Asia Investments have both backed the home fitness company, which will soon launch a smart display screen for its workouts.
Bioshin hoovers up $60m series A
The Biohaven spinoff has picked up $60m in its series A round as it expects to increase its headcount tenfold.
MEDx heads to series B round
Sinopharm Capital chipped in for a series B round aimed at expanding MEDx’s precision healthcare operation.